✨ Medicines and Local Government Notices
NEW ZEALAND GAZETTE, No. 61
31 MAY 2012
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Arrow - Oxycodone
Active Ingredient: Oxycodone hydrochloride 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: CP Pharmaceuticals Limited, Wrexham, United Kingdom
Product: CalSource Ca1200+D
Active Ingredients: Calcium carbonate 2100mg equivalent to Elemental calcium 840.8mg
Calcium lactate gluconate 2716mg equivalent to Clemental calcium 359.2mg
Colecalciferol 20μg
Dosage Form: Effervescent tablet
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: Famar France, Orleans Cedex, France
Product: Pamidronate BNM
Active Ingredient: Pamidronic acid 12.63mg/5mL equivalent to Disodium pamidronate 15mg/5mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Hikma Italia S.P.A, Pavia, Italy
Product: Pamidronate BNM
Active Ingredient: Pamidronic acid 25.27mg/10mL equivalent to Disodium pamidronate 30mg/10mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Hikma Italia S.P.A, Pavia, Italy
Product: Pamidronate BNM
Active Ingredient: Pamidronic acid 50.54mg/10mL equivalent to Disodium pamidronate 60mg/10mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Hikma Italia S.P.A, Pavia, Italy
Product: Pamidronate BNM
Active Ingredient: Pamidronic acid 75.82mg/10mL equivalent to Disodium pamidronate 90mg/10mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Hikma Italia S.P.A, Pavia, Italy
Dated this 23rd day of May 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3250
Internal Affairs
Local Government Act 2002
Pursuant to section 25 of the Local Government Act 2002, His Excellency the Governor-General of New Zealand, acting by and with the advice and consent of the Executive Council, makes the following order.
Order
Local Government (Manawatu District and Palmerston North City) Boundary Alteration Order 2012
Lt Gen The Rt Hon Sir Jerry Mateparae, Governor-General
ORDER IN COUNCIL
At Wellington this 28th day of May 2012
Present:
His Excellency the Governor-General Presiding in Council
-
Title—This order may be cited as Local Government (Manawatu District and Palmerston North City) Boundary Alteration Order 2012.
-
Commencement—This order comes into force on 1 July 2012.
-
Interpretation—In this order, unless the context otherwise requires:
Area A means the area marked as Area A on the maps deposited with the Local Government Commission for the purposes of this order. Areas B, C, D and E have the corresponding meaning.
Next Page →
✨ LLM interpretation of page content
🏥
Consent to Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare23 May 2012
Medicines, Distribution, Consent, Arrow - Oxycodone, CalSource Ca1200+D, Pamidronate BNM
- Dr Don Mackie, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏘️ Local Government Boundary Alteration Order
🏘️ Provincial & Local Government28 May 2012
Boundary Alteration, Manawatu District, Palmerston North City
- Lt Gen The Rt Hon Sir Jerry Mateparae, Governor-General
NZ Gazette 2012, No 61